highperformr logo

Parabilis Medicines's Overview

Total employees175
HeadquartersSan Diego
Founded2016

Parabilis Medicines is a preclinical stage biopharmaceutical company dedicated to the discovery and development of innovative protein-replacement therapies. Their primary focus is on addressing rare genetic diseases that currently have significant unmet medical needs, aiming to provide transformative treatments for patients. The company leverages scientific expertise to advance its pipeline of potential therapeutics through rigorous preclinical research.

Where is Parabilis Medicines's Headquarters?

HQ Function

Serves as the central hub for research and development operations, strategic planning, and corporate administration.

Notable Features:

Located in a prominent San Diego biotech corridor, likely providing access to modern laboratory facilities and collaborative office spaces designed for scientific innovation.

Work Culture:

Characterized by a science-driven, innovative, and collaborative environment typical of early-stage biotechnology firms. Emphasis is placed on research excellence, agility, and a patient-focused mission.

HQ Significance:

Strategic positioning within the San Diego life sciences cluster offers access to a rich talent pool, leading research institutions, and a supportive ecosystem for biotech advancement.

Values Reflected in HQ: The headquarters' location and setup reflect a commitment to scientific rigor, innovation, and efficient operations in the pursuit of therapeutic breakthroughs for rare diseases.

Location:

Currently, Parabilis Medicines is primarily focused on its preclinical research and development activities based in the United States. As the company's therapeutic candidates advance, its global functions and presence may expand to support clinical trials, regulatory affairs, and potential commercialization in key international markets.

Street Address:

9920 Pacific Heights Blvd., Suite 150

City:

San Diego

State/Province:

CA

Country:

USA

Parabilis Medicines's Global Presence

Buying Intent Signals for Parabilis Medicines

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Parabilis Medicines

As of April 2025, Parabilis Medicines' leadership includes:

Helen M. Boudreau, Ph.D. - President and Chief Executive Officer
Claus S. Schalper, Ph.D. - Co-Founder, Chief Scientific Officer
Frank H. Valone, M.D. - Co-Founder, Chief Medical Officer

Investors of Parabilis Medicines

Parabilis Medicines has been backed by several prominent investors over the years, including:

Privately Held
Seed Stage Investors
Angel Investors

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

No significant executive hires or departures have been publicly announced for Parabilis Medicines in the last 12 months. The company maintains a stable core leadership team focused on advancing its preclinical programs.

Technology (Tech Stack) used by Parabilis Medicines

Discover the tools Parabilis Medicines uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Parabilis Medicines Email Formats and Examples

Common email formats for companies like Parabilis Medicines often utilize a combination of the employee's first initial and last name, or first name and last name, followed by the company domain. For example, an employee named Jane Doe might have an email address like jdoe@parabilismedicines.com.

[first_initial][last]@parabilismedicines.com

Format

hboudreau@parabilismedicines.com

Example

75%

Success rate

News and media

Company Website & Industry ObservationMarch 15, 2024

Parabilis Medicines Actively Advancing Preclinical Pipeline for Rare Genetic Diseases

Parabilis Medicines continues its dedicated work in the preclinical phase, focusing on the development of its innovative protein-replacement therapies. The company's efforts are concentrated on validating its therapeutic candidates for rare genetic diseases with high unmet medical needs, with ongoing research to support future clinical development....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Parabilis Medicines, are just a search away.